000 | 01593 a2200421 4500 | ||
---|---|---|---|
005 | 20250513073949.0 | ||
264 | 0 | _c19931005 | |
008 | 199310s 0 0 eng d | ||
022 | _a0006-4971 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSpranzi, E | |
245 | 0 | 0 |
_aLysis of human monocytic leukemia cells by extracellular adenosine triphosphate: mechanism and characterization of the adenosine triphosphate receptor. _h[electronic resource] |
260 |
_bBlood _cSep 1993 |
||
300 |
_a1578-85 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _a4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid |
650 | 0 | 4 |
_a4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid _xanalogs & derivatives |
650 | 0 | 4 |
_aAdenosine Triphosphate _xanalogs & derivatives |
650 | 0 | 4 |
_aCalcium _xantagonists & inhibitors |
650 | 0 | 4 |
_aCalmodulin _xantagonists & inhibitors |
650 | 0 | 4 |
_aCell Death _xdrug effects |
650 | 0 | 4 |
_aCell Membrane _xdrug effects |
650 | 0 | 4 |
_aChelating Agents _xpharmacology |
650 | 0 | 4 |
_aChromium Radioisotopes _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterferon-gamma _xpharmacology |
650 | 0 | 4 |
_aMagnesium _xpharmacology |
650 | 0 | 4 | _aPurinergic Antagonists |
650 | 0 | 4 |
_aReceptors, Purinergic _xchemistry |
650 | 0 | 4 |
_aSignal Transduction _xphysiology |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTumor Cells, Cultured |
700 | 1 | _aDjeu, J Y | |
700 | 1 | _aHoffman, S L | |
700 | 1 | _aEpling-Burnette, P K | |
700 | 1 | _aBlanchard, D K | |
773 | 0 |
_tBlood _gvol. 82 _gno. 5 _gp. 1578-85 |
|
999 |
_c8363479 _d8363479 |